PAIGE FREEMAN: Open Payments
NPI 1275127789 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$989 in 28 payments from 12 companies in 2025. Trend: 2023 $347 · 2024 $765 · 2025 $989
Food & beverage: $890Education: $99
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $294 |
| ABBVIE INC. | 6 | $189 |
| SEAGEN INC. | 1 | $99 |
| Merck Sharp & Dohme LLC | 3 | $84 |
| Daiichi Sankyo Inc. | 3 | $75 |
| Genmab U.S., Inc. | 2 | $65 |
| Janssen Biotech, Inc. | 2 | $48 |
| TerSera Therapeutics LLC | 1 | $36 |
| Geron Corporation | 1 | $33 |
| Corcept Therapeutics | 1 | $28 |
Products named: ZEJULA, ELAHERE, KEYTRUDA, Tivdak, JEMPERLI, EPKINLY, Zoladex, RYTELO.
Industry payments across AZ — which companies pay providers there.
